BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 96 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,688,412 | -11.7% | 186,566 | +0.6% | 0.01% | 0.0% |
| Q2 2023 | $3,046,318 | +20.8% | 185,525 | +23.0% | 0.01% | 0.0% |
| Q1 2023 | $2,521,260 | +50.2% | 150,883 | +38.7% | 0.01% | +66.7% |
| Q4 2022 | $1,678,310 | +7.3% | 108,769 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $1,564,000 | +21.5% | 104,735 | +33.7% | 0.00% | 0.0% |
| Q2 2022 | $1,287,000 | -7.2% | 78,308 | +13.3% | 0.00% | 0.0% |
| Q1 2022 | $1,387,000 | -8.4% | 69,130 | +15.8% | 0.00% | 0.0% |
| Q4 2021 | $1,514,000 | -26.8% | 59,717 | -22.1% | 0.00% | -25.0% |
| Q3 2021 | $2,067,000 | +21.4% | 76,622 | +30.1% | 0.00% | +33.3% |
| Q2 2021 | $1,703,000 | +25.9% | 58,881 | +14.5% | 0.00% | 0.0% |
| Q1 2021 | $1,353,000 | +6.0% | 51,435 | +15.5% | 0.00% | 0.0% |
| Q4 2020 | $1,276,000 | +245.8% | 44,543 | +152.5% | 0.00% | +200.0% |
| Q2 2020 | $369,000 | +30.9% | 17,641 | +12.0% | 0.00% | 0.0% |
| Q1 2020 | $282,000 | – | 15,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |